Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
32.96
+0.12 (0.37%)
Aug 18, 2026, 4:00 PM EDT - Market closed

Genmab Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Dec '22 Dec '21
Cash & Equivalents
1,5031,7151,3802,2041,4211,370
Short-Term Investments
--1,5741,9671,7861,588
Cash & Short-Term Investments
1,5101,7152,9544,1713,2072,958
Cash Growth
-47.91%-41.94%-29.18%30.04%8.44%11.94%
Accounts Receivable
1,2051,112923733820.69515
Other Receivables
684014-26.154.74
Receivables
1,2731,152937733846.84519.75
Inventory
181898--
Total Current Assets
2,8012,8853,9004,9124,0543,478
Property, Plant & Equipment
254280265244189.94149.13
Long-Term Investments
3937322019.1156.75
Goodwill
355355355---
Other Intangible Assets
8,8729,1231,7281520.9838.85
Long-Term Accounts Receivable
21227106.94.13
Long-Term Deferred Tax Assets
1731711273136.2140.38
Total Assets
12,51512,8736,4145,2324,3273,767

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Dec '22 Dec '21
Accounts Payable
-----53.53
Accrued Expenses
-----45.28
Current Portion of Long-Term Debt
294273----
Current Portion of Leases
1818131310.639.48
Current Income Taxes Payable
-432398--
Current Unearned Revenue
2124354.743.98
Other Current Liabilities
8071,069489342246.55127.57
Total Current Liabilities
1,1401,427744368261.93239.84
Long-Term Debt
4,8415,001----
Long-Term Leases
12013413110175.1455.52
Long-Term Unearned Revenue
8895677168.9774.49
Long-Term Deferred Tax Liabilities
364364330---
Other Long-Term Liabilities
55551.581.99
Total Liabilities
6,5587,0261,277545407.62371.84

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Dec '22 Dec '21
Common Stock
101010109.4810.1
Additional Paid-In Capital
1,9231,9201,9611,9421,7691,840
Retained Earnings
4,4214,0983,3922,7372,1281,533
Comprehensive Income & Other
-397-181-226-214.0812.39
Shareholders' Equity
5,9575,8475,1374,6873,9203,395
Total Liabilities & Equity
12,51512,8736,4145,2324,3273,767

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Dec '22 Dec '21
Total Debt
5,2735,42614411485.7865.01
Net Cash (Debt)
-3,763-3,7112,8104,0573,1222,893
Net Cash Growth
---30.74%29.96%7.91%11.69%
Net Cash Per Share
-60.37-59.1943.4661.5747.2943.80
Filing Date Shares Outstanding
59.761.6263.5465.3365.3765.43
Total Common Shares Outstanding
59.761.6263.5465.3365.3765.43
Working Capital
1,6611,4583,1564,5443,7923,238
Book Value Per Share
99.7894.8980.8571.7459.9651.89
Tangible Book Value
-3,270-3,6313,0544,6723,8993,356
Tangible Book Value Per Share
-54.77-58.9348.0671.5159.6451.29
Machinery
-17513913593.2582.14
Construction In Progress
-314633.487.95
Leasehold Improvements
-13210110159.261.18
SEC Filings: 10-K · 10-Q